Back
NovoCure Vs. John Wiley & Sons Industry Stock Comparison
Sell
27
NVCR
NovoCure
Last Price:
18.04
Seasonality Move:
10.33%
Buy
52
WLY
John Wiley & Sons
Last Price:
39.85
Seasonality Move:
1.66%
Sell
27
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $18.04. The Score for NVCR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
John Wiley & Sons (WLY)
is a Buy
Is John Wiley & Sons a Buy, Sell or Hold?
- The current John Wiley & Sons [WLY] share price is $40.68. The Score for WLY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- WLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WLY Stock Price Chart
What is John Wiley & Sons's stock price today?
-
The John Wiley & Sons share price today is $40.68
The current trend is moderately bullish and WLY is experiencing slight selling pressure.
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 36.48 | Sell |
| Chaikin Money Flow: | -1057603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.91 - 23.21) | Sell |
| Bollinger Bands (100): | (13.11 - 20.09) | Buy |
WLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.82 | Buy |
| Relative Strength Index (14 RSI): | 67.18 | Buy |
| Chaikin Money Flow: | -64258 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.94 - 39.64) | Buy |
| Bollinger Bands (100): | (34.67 - 38.95) | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.59 | Sell |
| 20-day SMA: | 21.15 | Sell |
| 50-day SMA: | 18.23 | Sell |
| 200-day SMA: | 15.44 | Buy |
| 8-day EMA: | 19.42 | Sell |
| 20-day EMA: | 20.2 | Sell |
| 50-day EMA: | 19 | Sell |
| 200-day EMA: | 21.74 | Sell |
WLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.25 | Buy |
| 20-day SMA: | 37.79 | Buy |
| 50-day SMA: | 37.92 | Buy |
| 200-day SMA: | 34.63 | Buy |
| 8-day EMA: | 39.75 | Buy |
| 20-day EMA: | 38.65 | Buy |
| 50-day EMA: | 37.87 | Buy |
| 200-day EMA: | 36.24 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.00 per share, an increase this year of $0.42 per share, and a decrease next year of $0.11 per share.
John Wiley & Sons Earnings Growth & WLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.51 per share, a decrease next quarter of $0.23 per share, a decrease this year of $1.00 per share, and an increase next year of $1.00 per share.
NovoCure Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
John Wiley & Sons Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||